- Home
- Companies
- canada nova scotia
- therapy development
Show results for
Refine by
Therapy Development Suppliers Serving Canada Nova Scotia
67 companies found
based inCambridge, MASSACHUSETTS (USA)
Alnylam is the Leading RNAi Therapeutics Company. Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an innovative, entirely new class of medicines. Founded in 2002 by a team of distinguished life ...
based inWashington, DISTRICT OF COLUMBIA (USA)
The Alliance for Regenerative Medicine (ARM) is the leading international advocacy organization dedicated to realizing the promise of regenerative medicines and advanced therapies. ARM promotes legislative, regulatory, reimbursement and ...
based inIrvine, CALIFORNIA (USA)
Fluxergy started 10 years ago by Ryan Revilla and Tej Patel with a vision to democratize the world of laboratory testing, by making testing more accessible and affordable. Fluxergy’s platform technology enables us to understand our world and our ...
based inMinneapolis, MINNESOTA (USA)
CVRx is a leader in innovative technologies that address the unmet needs in cardiovascular diseases with safe and effective therapies. The company has developed proprietary implantable technology for the treatment of high blood pressure and heart ...
based inWroclaw, POLAND
Pure Biologics is a biopharmaceutical company focused on the biological drug and non-systemic therapies discovery and development. We operate in the areas of immuno-oncology, autoimmunology, and rare neurological diseases, conducting research based ...
based inBochum, GERMANY
Medical products for minimally invasive pain therapy on the spine. Development, experience and competence since 1999. Radimed GmbH develops and sells products for pain therapy on the spine with a focus on methods between conventional therapy and ...
based inIrvine, CALIFORNIA (USA)
Endologix LLC is a California-based, global medical device company dedicated to improving patients’ lives by providing innovative therapies for the interventional treatment of vascular disease. With a robust pipeline of disruptive technology, our ...
based inCharlottesville, VIRGINIA (USA)
LumaCyte is an advanced research and bioanalytics instrumentation company that produces label-free, single cell analysis instrumentation where the use of antibody or genetic labeling is not required for cellular analysis. This revolutionary ...
based inSomerset, NEW JERSEY (USA)
As the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world, we conduct all our business responsibly and with integrity. Our ...
based inSouth Melbourne, AUSTRALIA
BioDiem is an Australian biopharmaceutical company that is focused on developing and commercialising vaccines and infectious disease therapies. Our business model is to generate income from partnerships including with other vaccine and infectious ...
based inBoston, MASSACHUSETTS (USA)
At Emulate, we understand that animal studies and reductionist models are limited because they are not based on integrated human biology. By leveraging 21st century technologies, we are able to overcome these limitations with living human in vitro ...
based inSyracuse, NEW YORK (USA)
Mesothelioma is an aggressive cancer that affects the lining of the lungs, heart, or abdomen. Caused by the inhalation of asbestos fibers, mesothelioma is often diagnosed in older individuals who worked with asbestos products. Prognosis for ...
based inSant Vicenç dels Horts, SPAIN
We design, develop, manufacture and assemble components, semi-finished products, and final devices for Interventional Radiology and Cardiology using proprietary know-how and technologies. Founded and based in Barcelona by a team of more than 60 ...
based inSan Francisco, CALIFORNIA (USA)
MiLaboratories is the leader in immunome data analysis software with flagship product MiXCR. We provide a secure, scalable, and fast solution that helps thousands of researchers around the globe to discover new drugs and therapies. We develop ...
based inNottingham, UNITED KINGDOM
Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based ...
based inHaifa, ISRAEL
Pluristem Therapeutics Inc. is a clinical-stage regenerative medicine company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for conditions such as inflammation, muscle injuries, ...
Bone marrow deficiency refers to a condition in which the hematopoietic stem cells in the bone marrow fail to produce enough, or produce abnormal, red blood cells, white blood cells and platelets. Hematopoietic cell transplantation (HCT), the ...
based inRimbach, GERMANY
gbo Medizintechnik AG is an established medium-sized company and sells and supports its products in over 70 countries worldwide. gbo is known as a manufacturer of medical products. Less well known, but no less significant, is the fact that we ...
based inTaipei, TAIWAN
Lumosa Therapeutics is a clinical-stage pharmaceutical company dedicating to develop novel therapies and solutions for neurological and oncological diseases with urgent unmet medical need. Besides of using Lumosa's own technology platform in drug ...
based inCheshire, UNITED KINGDOM
Blueberry Therapeutics’ vision is to bring high value, innovative medicines to the market that make a real difference to people’s lives. We have exclusive worldwide access to a nanodelivery platform, which significantly enhances delivery of drugs ...
based inShirley, NEW YORK (USA)
After decades of research and accumulation, Creative Biolabs has become a leader in the discovery and manufacturing of recombinant antibodies (rAbs), providing the most reliable and qualified services to customers in academia and industry around the ...
Insults to the central nervous system can lead to severe motor impairments in gait or fine motor skills. To develop therapies for motor dysfunction, animal models which have a disease pathophysiology comparable to ...
